Feb. 10, 2024

Navigating Bispecific Antibodies in Myeloma Care with Alfred Garfall, MD and Bea Razzo

Jan. 09, 2024

The 2024 Multiple Myeloma Landscape with Robert Orlowski, MD, PhD, MD Anderson Cancer Center

Oct. 27, 2023

Today's CAR T Options in Multiple Myeloma Care with Luciano Costa, MD, UAB

Sep. 22, 2023

A Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

Sep. 20, 2023

Stem Cell Transplant Advances and Use in the Age of Immunotherapy

Aug. 30, 2023

Essential Research for Myeloma Cures with Faith Davies, MBBCh, MRCP, MD, FRCPath, NYU Langone

Jul. 07, 2023

The Utility of MRD Testing for Myeloma Patient Treatment and Outcomes with Benjamin Derman, MD

May. 31, 2023

Understanding More Sensitive Blood-Based Testing in Multiple Myeloma with Ola Landgren, MD, PhD

Feb. 01, 2023

The New "Moda" in Multiple Myeloma: Modafakusp Alpha Targeting CD38 with Noa Biran, MD

Jan. 17, 2023

Myeloma Innovation in 2023 - An Annual Review

Nov. 14, 2022

The Approval of Teclistamab in Multiple Myeloma with Alfred Garfall, MD, UPENN

Oct. 31, 2022

Kidney Disease and Multiple Myeloma with Natalie Callander, MD, University of Wisconsin at Madison

Oct. 21, 2022

New Maintenance Strategies for Newly Diagnosed Myeloma Patients With Ashraf Badros, MD, University of Maryland

Jul. 18, 2022

A Mid-Year Myeloma Review with Paul Richardson, MD, Dana Farber Cancer Institute

Jun. 27, 2022

Allo CAR T Myeloma Therapies with Jesus Berdeja, MD, Sarah Cannon Research Institute

Feb. 07, 2022

Looking Forward into 2022 in Multiple Myeloma With Robert Orlowski, MD, PHD, MD Anderson Cancer Center

Jan. 06, 2022

Engineered Toxin Bodies Targeting CD38 in Myeloma with Shaji Kumar, MD, Mayo Clinic

Jan. 05, 2022

Tasquinimod As a New Myeloma Therapy with Dan Vogl, MD and Yulia Nefedova, MD, PhD